TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹1,847 Cr | ₹1,226 Cr | ₹1,526 Cr | ₹1,187 Cr | ₹562 Cr |
What is the latest Profit Before Tax of TORRENT PHARMACEUTICALS ?
Year | Profit Before Tax |
---|---|
Mar2024 | ₹1,847 Cr |
Mar2023 | ₹1,226 Cr |
Mar2022 | ₹1,526 Cr |
Mar2021 | ₹1,187 Cr |
Mar2020 | ₹562 Cr |
How is Profit Before Tax of TORRENT PHARMACEUTICALS Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,847 Cr | 50.68 | |
Mar2023 | ₹1,226 Cr | -19.68 | |
Mar2022 | ₹1,526 Cr | 28.63 | |
Mar2021 | ₹1,187 Cr | 111.26 | |
Mar2020 | ₹562 Cr | - |
Compare Profit Before Tax of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹116,215.0 Cr | 2.2% | 10.6% | 61.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 2.2% |
10.6% |
61.7% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses